CSPC Historical Income Statement

300765 Stock

28.51 0.27 0.94%

Historical analysis of CSPC Innovation income statement accounts such as Net Interest Income of 68.5 M, Interest Income of 69.2 M or Interest Expense of 555.6 K can show how well CSPC Innovation Pharmaceutical performed in making a profits. Evaluating CSPC Innovation income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CSPC Innovation's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining CSPC Innovation Phar latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CSPC Innovation Phar is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSPC Innovation Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About CSPC Income Statement Analysis

CSPC Innovation Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CSPC Innovation shareholders. The income statement also shows CSPC investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

CSPC Innovation Income Statement Chart

At present, CSPC Innovation's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 69.2 M, whereas Tax Provision is forecasted to decline to about 82.2 M.

Tax Provision Selling General Administrative Total Revenue Gross Profit Research Development

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts CSPC Innovation Phar generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of CSPC Innovation Pharmaceutical minus its cost of goods sold. It is profit before CSPC Innovation operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from CSPC Innovation's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CSPC Innovation Phar current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSPC Innovation Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	685.9M	1.1B	1.1B	806.6M
Total Revenue	1.4B	2.6B	2.5B	1.7B

Gross Profit Total Revenue

CSPC Innovation income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Ebitda	Reconciled Depreciation
Tax Provision		0.83	0.82	0.48	0.99	0.98	0.55	1.0	0.99	0.88	0.99	0.98	0.98	0.99	0.99	0.99	-0.85	0.89	0.97
Net Interest Income	0.83		1.0	0.42	0.8	0.81	0.45	0.81	0.8	0.97	0.8	0.79	0.79	0.81	0.8	0.81	-0.9	0.96	0.87
Interest Income	0.82	1.0		0.4	0.8	0.8	0.47	0.81	0.8	0.97	0.8	0.78	0.79	0.8	0.8	0.8	-0.9	0.96	0.87
Selling General Administrative	0.48	0.42	0.4		0.5	0.62	-0.07	0.43	0.37	0.37	0.35	0.41	0.54	0.38	0.37	0.46	-0.36	0.45	0.5
Total Revenue	0.99	0.8	0.8	0.5		0.99	0.55	0.99	0.98	0.87	0.98	0.99	1.0	0.98	0.98	0.97	-0.85	0.89	0.94
Gross Profit	0.98	0.81	0.8	0.62	0.99		0.45	0.98	0.96	0.85	0.95	0.96	0.99	0.96	0.96	0.97	-0.82	0.88	0.95
Other Operating Expenses	0.55	0.45	0.47	-0.07	0.55	0.45		0.56	0.57	0.49	0.6	0.61	0.54	0.57	0.57	0.56	-0.55	0.49	0.5
Operating Income	1.0	0.81	0.81	0.43	0.99	0.98	0.56		1.0	0.88	0.99	0.99	0.98	1.0	1.0	0.98	-0.84	0.89	0.96
Net Income From Continuing Ops	0.99	0.8	0.8	0.37	0.98	0.96	0.57	1.0		0.87	1.0	0.99	0.97	1.0	1.0	0.97	-0.83	0.88	0.95
Ebit	0.88	0.97	0.97	0.37	0.87	0.85	0.49	0.88	0.87		0.87	0.87	0.86	0.88	0.87	0.84	-0.91	0.99	0.88
Research Development	0.99	0.8	0.8	0.35	0.98	0.95	0.6	0.99	1.0	0.87		0.99	0.97	1.0	1.0	0.98	-0.86	0.87	0.94
Cost Of Revenue	0.98	0.79	0.78	0.41	0.99	0.96	0.61	0.99	0.99	0.87	0.99		0.99	0.99	0.99	0.97	-0.86	0.88	0.92
Total Operating Expenses	0.98	0.79	0.79	0.54	1.0	0.99	0.54	0.98	0.97	0.86	0.97	0.99		0.97	0.97	0.97	-0.85	0.88	0.93
Income Before Tax	0.99	0.81	0.8	0.38	0.98	0.96	0.57	1.0	1.0	0.88	1.0	0.99	0.97		1.0	0.98	-0.83	0.88	0.96
Net Income	0.99	0.8	0.8	0.37	0.98	0.96	0.57	1.0	1.0	0.87	1.0	0.99	0.97	1.0		0.97	-0.83	0.88	0.95
Income Tax Expense	0.99	0.81	0.8	0.46	0.97	0.97	0.56	0.98	0.97	0.84	0.98	0.97	0.97	0.98	0.97		-0.86	0.85	0.97
Minority Interest	-0.85	-0.9	-0.9	-0.36	-0.85	-0.82	-0.55	-0.84	-0.83	-0.91	-0.86	-0.86	-0.85	-0.83	-0.83	-0.86		-0.88	-0.81
Ebitda	0.89	0.96	0.96	0.45	0.89	0.88	0.49	0.89	0.88	0.99	0.87	0.88	0.88	0.88	0.88	0.85	-0.88		0.9
Reconciled Depreciation	0.97	0.87	0.87	0.5	0.94	0.95	0.5	0.96	0.95	0.88	0.94	0.92	0.93	0.96	0.95	0.97	-0.81	0.9

Click cells to compare fundamentals

CSPC Innovation Account Relationship Matchups

CSPC Innovation income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	61.6M	65.5M	70.6M	124.8M	136.5M	82.2M
Net Interest Income	696.2K	8.2M	27.1M	31.6M	65.3M	68.5M
Interest Income	2.4M	8.6M	27.3M	32.7M	65.9M	69.2M
Interest Expense	1.5M	33.7K	58.6K	219.2K	355.6K	555.6K
Selling General Administrative	315.0M	339.2M	273.2M	262.4M	249.5M	295.7M
Total Revenue	1.3B	1.3B	1.4B	2.6B	2.5B	1.7B
Gross Profit	644.7M	733.2M	685.9M	1.1B	1.1B	806.6M
Other Operating Expenses	17.0M	1.6M	15.8M	19.9M	22.9M	15.4M
Operating Income	304.4M	342.7M	363.6M	759.7M	783.1M	453.3M
Net Income From Continuing Ops	273.5M	299.7M	316.5M	726.6M	755.3M	412.1M
Ebit	285.7M	344.1M	434.9M	747.1M	859.2M	902.2M
Research Development	13.1M	14.0M	20.4M	46.3M	46.5M	23.3M
Cost Of Revenue	611.8M	584.2M	746.1M	1.5B	1.4B	884.1M
Total Operating Expenses	952.1M	974.7M	1.1B	1.9B	1.7B	1.2B
Income Before Tax	335.2M	365.2M	387.1M	851.4M	891.8M	494.4M
Net Income Applicable To Common Shares	273.2M	299.8M	393.2M	726.3M	835.2M	877.0M
Net Income	273.2M	299.8M	317.1M	726.3M	755.6M	412.1M
Income Tax Expense	61.6M	65.5M	85.3M	124.8M	143.5M	74.9M
Minority Interest	8.9M	8.8M	527.9K	(333.8K)	239.7K	227.7K
Ebitda	383.8M	418.6M	438.5M	924.5M	1.1B	1.1B
Reconciled Depreciation	47.1M	53.4M	51.4M	72.9M	100.1M	63.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in CSPC Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CSPC Historical Income Statement

About CSPC Income Statement Analysis

CSPC Innovation Income Statement Chart

Tax Provision

Total Revenue

Gross Profit

CSPC Innovation income statement Correlations

CSPC Innovation Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CSPC Innovation income statement Accounts

Also Currently Popular

Other Information on Investing in CSPC Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Operating Income	+ 1.0	Tax Provision
Interest Income	+ 1.0	Net Interest Income
Total Operating Expenses	+ 1.0	Total Revenue
Net Income From Continuing Ops	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income

Minority Interest	- 0.91	Ebit
Minority Interest	- 0.9	Interest Income
Minority Interest	- 0.9	Net Interest Income
Ebitda	- 0.88	Minority Interest
Minority Interest	- 0.86	Income Tax Expense
Minority Interest	- 0.86	Cost Of Revenue